Tiina Leppänen

Activities

Activities per year 2005 2018 2019 2020

• 99 Conference presentation
• 1 Invited lecture

Activities per year

Search results

• Anti-Inflammatory and anti-catabolic effects of dexamethasone are mediated through MKP-1 in murine models

  T Myyry (Contributor), T Leppänen (Contributor), R Nieminen (Contributor), L Tuure (Contributor) & E Moilanen (Contributor)

  13 Feb 2020

  Activity: Talk or presentation › Conference presentation

• TRPA1 mediates DNCB-induced allergic contact dermatitis

  I Mäki-Opas (Contributor), M Hämäläinen (Contributor), LJ Moilanen (Contributor), H Sood (Contributor), T Leppänen (Contributor), L Lehtimäki (Contributor) & E Moilanen (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory and anti-catabolic effects of dexamethasone are mediated through MKP-1 in murine models

  Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory mechanisms of PDE4 inhibitors: Rolipram induces macrophage polarization from inflammatory (M1) to healing promoting (M2) phenotype through MKP-1

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  29 Nov 2019

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory mechanisms of PDE4 inhibitors: Rolipram induces macrophage polarization from inflammatory (M1) to healing promoting (M2) phenotype through MKP-1 phosphatase

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  15 Sep 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  A Pemmari (Contributor), L Tuure (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  2 May 2019

  Activity: Talk or presentation › Conference presentation

• CAMP enhancing drugs salbutamol and rolipram augment alternative macrophage activation through MKP-1

  T Kivistö (Contributor), M Scotece (Contributor), M Hämäläinen (Contributor) & E Moilanen (Contributor)

  20 Mar 2019

  Activity: Talk or presentation › Conference presentation

• Mitogen-activated protein kinase phosphatase 1 (MKP-1) as a mediator of anti-inflammatory and anti-catabolic effects of dexamethasone

  T Myyry (Contributor), T Leppänen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)

  20 Mar 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  20 Mar 2019

  Activity: Talk or presentation › Conference presentation

• Comprehensive effects of ibuprofen on gene expression in chondrocytes as determined by RNA-Seq

  A Pemmari (Speaker), L Tuure (Speaker), M Hämäläinen (Speaker), T Leppänen (Speaker), K Vuolteenaho (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• PDE4 inhibitor rolipram augments the alternative activation of murine macrophages through MKP-1

  Tiina Leppänen (Speaker), Mari Hämäläinen (Speaker), Eeva Moilanen (Speaker), Tiina Myyry (Speaker) & Riina Nieminen (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• The effects of dexamethasone on inflammatory and catabolic factors in chondrocytes are mediated through MKP-1

  Tiina Myyry (Speaker), Tiina Leppänen (Speaker), Eeva Moilanen (Speaker) & Riina Nieminen (Speaker)

  24 Jan 2019

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  M Laavola (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• CAMP enhancing drugs salbutamol and rolipram augment the alternative activation of murine macrophages through MKP-1

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor) & Eeva Moilanen (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• Gene expression in adverse reaction to metal debris around metal-on-metal arthroplasty: an RNA-Seq-based study

  A Pemmari (Speaker), T Penttilä (Speaker), EL Paukkeri (Speaker), A Eskelinen (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• MKP-1 as a novel factor in the pathogenesis of scleroderma. An experimental study

  Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• MAP kinase phosphatase-1 (MKP-1) as a target of anti-inflammatory drug treatment: Anti-inflammatory effects of the glucocorticoid dexamethasone are mediated by MKP-1 in murine models

  R Nieminen (Contributor), A Pemmari (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor) & E Moilanen (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory properties of the ?2-receptor agonist salbutamol and the PDE4 inhibitor rolipram are mediated by MKP-1

  Mari Hämäläinen (Contributor), Riku Korhonen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  Tiina Leppänen (Contributor), Mari Hämäläinen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  23 Nov 2018

  Activity: Talk or presentation › Conference presentation

• MAP kinase phosphatase-1 (MKP-1) as a target of anti-inflammatory drug treatment: Anti-inflammatory effects of the glucocorticoid dexamethasone are mediated by MKP-1 in murine models

  Riina Nieminen (Speaker), Mari Hämäläinen (Speaker), Tiina Leppänen (Speaker) & Eeva Moilanen (Speaker)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  M Laavola (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), K Vuolteenaho (Contributor), T Moilanen (Contributor), R Nieminen (Contributor) & E Moilanen (Contributor)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• Novel adipokine associated with osteoarthritis: retinol binding protein 4 is produced by cartilage and correlates with matrix metalloproteinases in osteoarthritis patients

  M Scotece (Contributor), A Koskinen-Kolasa (Contributor), A Pemmari (Contributor), T Leppänen (Contributor), M Hämäläinen (Contributor), T Moilanen (Contributor), E Moilanen (Contributor) & K Vuolteenaho (Contributor)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• MKP-1 as a novel factor in the pathogenesis of scleroderma. An experimental study

  Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis

  A Pemmari (Speaker), T Syvänen (Speaker), M Hämäläinen (Speaker), T Moilanen (Speaker), K Vuolteenaho (Speaker) & E Moilanen (Speaker)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory properties of the ?2-receptor agonist salbutamol and the PDE4 inhibitor rolipram are mediated by MKP-1

  Mari Hämäläinen (Contributor), Riku Korhonen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• CAMP enhancing drugs salbutamol and rolipram augment the alternative activation of murine macrophages through MKP-1

  Tiina Leppänen (Contributor), Mari Mäkinen (Contributor) & Eeva Moilanen (Contributor)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• Gene expression in adverse reaction to metal debris around metal-on-metal arthroplasty: an RNA-Seq-based study

  A Pemmari (Contributor), T Leppänen (Contributor), E-L Paukkeri (Contributor), A Eskelinen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  5 Sep 2018

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory properties of the ?2-receptor agonist salbutamol and the PDE4 inhibitor rolipram are mediated by MKP-1

  T Keränen (Contributor), T Hömmö (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor), E Moilanen (Contributor) & R Korhonen (Contributor)

  1 Jun 2018

  Activity: Talk or presentation › Conference presentation

• Gene expression in adverse reaction to metal debris around metal-on metal arthroplasty: an RNA-Seq-based study

  Antti Pemmari (Contributor), Tiina Syrjäläinen (Contributor) & Eeva Moilanen (Contributor)

  26 Apr 2018

  Activity: Talk or presentation › Conference presentation

• MKP-1 as a novel factor in the pathogenesis of scleroderma. An experimental study

  Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• MAP kinase phosphatase-1 (MKP-1) as a target of anti-inflammatory drug treatment: Anti-inflammatory effects of the glucocorticoid dexamethasone are mediated by MKP-1 in vitro and in vivo models

  R Nieminen (Contributor), A Pemmari (Contributor), M Hämäläinen (Contributor), T Leppänen (Contributor) & E Moilanen (Contributor)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing-based genome wide expression analysis

  Antti Pemmari (Speaker), Mari Hämäläinen (Speaker), Tiina Leppänen (Speaker), Eeva Moilanen (Speaker) & Katriina Vuolteenaho (Speaker)

  24 Apr 2018

  Activity: Talk or presentation › Conference presentation

• Gene expression in adverse reaction to metal debris around metal-on-metal arthroplasty: an RNA-Seq-based study

  A Pemmari (Contributor), T Leppänen (Contributor), EL Paukkeri (Contributor), A Eskelinen (Contributor), T Moilanen (Contributor) & E Moilanen (Contributor)

  21 Mar 2018

  Activity: Talk or presentation › Conference presentation

• Anti-inflammatory properties of the ?2-receptor agonist salbutamol and the PDE4 inhibitor rolipram are mediated by MKP-1

  Tiina Keränen (Contributor), Mari Hämäläinen (Contributor), Riku Korhonen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  21 Mar 2018

  Activity: Talk or presentation › Conference presentation

• IL-6 in osteoarthritis: effects of pinosylvin and monomethyl pinosylvin

  M Laavola (Speaker), T Leppänen (Speaker), M Hämäläinen (Speaker), K Vuolteenaho (Speaker), T Moilanen (Speaker), R Nieminen (Speaker) & E Moilanen (Speaker)

  25 Jan 2018

  Activity: Talk or presentation › Conference presentation

• Gene expression in adverse reaction to metal debris around metal-on-metal arthroplasty: an RNA-Seq-based study

  A Pemmari (Speaker), T Leppänen (Speaker), T Moilanen (Speaker) & E Moilanen (Speaker)

  25 Jan 2018

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by next generation sequencing -based genome wide expression analysis

  Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  3 Nov 2017

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by RNA-Seq-based genome wide expression analysis

  Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Katriina Vuolteenaho (Contributor)

  26 Oct 2017

  Activity: Talk or presentation › Conference presentation

• MKP-1 as a protective factor and novel drug target in scleroderma: MKP-1 deficient mice develop more severe dermal fibrosis in a widely used experimental model of scleroderma

  Morena Scotece (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  26 Oct 2017

  Activity: Talk or presentation › Conference presentation

• CAMP enhancing drugs salbutamol and rolipram augment the alternative activation of murine macrophages through MKP-1

  Tiina Leppänen (Speaker), Mari Hämäläinen (Speaker) & Eeva Moilanen (Speaker)

  11 Jul 2017

  Activity: Talk or presentation › Conference presentation

• MKP-1 as a protective factor and novel drug target in scleroderma: MKP-1 deficient mice develop more severe dermal fibrosis in a widely used experimental model of scleroderma

  Morena Scotece (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  14 Jun 2017

  Activity: Talk or presentation › Conference presentation

• MKP-1 as a protective factor and novel drug target in scleroderma: MKP-1 deficient mice develop more severe dermal fibrosis in a widely used experimental model of scleroderma

  Morena Scotece (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  22 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by NGS-based genome wide expression analysis

  Antti Pemmari (Contributor), Mari Hämäläinen (Contributor), Tiina Leppänen (Contributor) & Eeva Moilanen (Contributor)

  22 Mar 2017

  Activity: Talk or presentation › Conference presentation

• Widespread regulation of gene expression by glucocorticoids in chondrocytes from OA patients as determined by NGS-based genome wide expression analysis

  Antti Pemmari (Speaker), Mari Hämäläinen (Speaker), Tiina Leppänen (Speaker) & Eeva Moilanen (Speaker)

  27 Jan 2017

  Activity: Talk or presentation › Conference presentation

• Enhanced severity of experimentally-induced dermal scleroderma in mitogen-activated protein kinase phosphatase-1 (MKP-1) deficient mice

  Morena Scotece (Speaker), M Hämäläinen (Speaker), T Leppänen (Speaker) & E Moilanen (Speaker)

  27 Jan 2017

  Activity: Talk or presentation › Conference presentation

• Synthesis of psoralen derivatives and their anti-inflammatory properties. Emerging tarhets and molecules in middle space

  J Timonen (Contributor), K Vuolteenaho (Contributor), T Leppänen (Contributor), R Nieminen (Contributor), P Aulaskari (Contributor), J Jänis (Contributor), P Vainiotalo (Contributor) & E Moilanen (Contributor)

  24 Aug 2015

  Activity: Talk or presentation › Conference presentation

• YKL-40, a NOVEL marker of inflammation, is elevated after coronary artery bypass grafting surgery and correlates with troponin T release

  Antti Laurikka (Contributor), Mari Hämäläinen (Contributor), Jari Laurikka (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor), Matti Tarkka (Contributor) & Katriina Vuolteenaho (Contributor)

  19 Mar 2014

  Activity: Talk or presentation › Conference presentation

• PI3K/Akt Pahtway as an anti-inflammatory drug target

  Heikki Eräsalo (Contributor), Mari Hämäläinen (Contributor), Mirka Laavola (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  19 Mar 2014

  Activity: Talk or presentation › Conference presentation

• PI3K/Akt pathway as an anti-inflammatory drug target

  Heikki Eräsalo (Contributor), Mari Hämäläinen (Contributor), Mirka Laavola (Contributor), Tiina Leppänen (Contributor), Eeva Moilanen (Contributor) & Riina Nieminen (Contributor)

  13 Feb 2014

  Activity: Talk or presentation › Conference presentation